Development of forced degradation and stability indicating studies of drugs-A review

来源 :药物分析学报(英文) | 被引量 : 0次 | 上传用户:xxxmmm1236
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Forced degradation is a degradation of new drug substance and drug product at conditions more severe than accelerated conditions. It is required to demonstrate specificity of stability indicating methods and also provides an insight into degradation pathways and degradation products of the drug substance and helps in elucidation of the structure of the degradation products. Forced degradation studies show the chemical behavior of the molecule which in t helps in the development of formulation and package. In addition, the regulatory guidance is very general and does not explain about the performance of forced degradation studies. Thus, this review discusses the current trends in performance of forced degradation studies by providing a strategy for conducting studies on degradation mechanisms and also describes the analytical methods helpful for development of stability indicating method.
其他文献
1例63岁女性患者因非霍奇金淋巴瘤拟行R-CHOP(利妥昔单抗、环磷酰胺、阿霉素、长春新碱、泼尼松龙)方案治疗。首日给予利妥昔单抗600 mg加入0.9%氯化钠注射液750 ml静脉滴注,同时给予水化、碱化、保护脏器功能、预防不良反应等治疗。第2天患者出现四肢不自主抖动、双下肢乏力、反应略迟钝和行走不稳,头颅磁共振成像检查未见异常;第3天出现发热、认知障碍;第4天不能自主进食及自主排便。给予甲泼尼
目的探讨尿道扩张术治疗女性膀胱出口梗阻的效果。方法选取女性膀胱出口梗阻患者35例,均应用α受体阻滞剂治疗无效,在局部麻醉下行尿道扩张术,每周1次,共12次。治疗前后分别测定国际前列腺症状评分(IPSS)、生命质量评分(QOL)及残余尿量。结果患者治疗后IPSS、QOL和残余尿量均较治疗前明显降低[(10.23±6.31)分比(21.41±3.71)分、(2.31±0.65)分比(5.43±0.60
目的评价经角膜上皮的激光角膜切削术(T-PRK)矫正飞秒激光小切口角膜基质透镜取出术(SMILE)后屈光回退的效果。方法回顾性分析2015年1月至2015年12月行SMILE手术403例(799只眼)中出现屈光回退的9只眼的临床资料。对患者均以T-PRK进行二次矫正(增效手术),于术后1周、1、3及6个月进行随访,观察视力、屈光度和并发症。结果T-PRK术后1周裸眼视力均达到1.0,且术后仅1只眼
AIM: To explore the prevalence of gallstone disease (GSD) in Taiwan and condition-associated factors related to it.METHODS: We studied a total of 2386 healthy a
期刊
期刊
山东省中药资源丰富,中药文化底蕴深厚。进入"新常态",齐鲁中药文化保护面临的问题为缺乏对齐鲁中药文化内涵的深度挖掘、保护方法创新性不足、保护方式系统性不足。因此,有
期刊
4例女性患者(年龄分别为17、14、25和20岁)因系统性红斑狼疮(例1、2合并Ⅳ型狼疮性肾炎)接受大剂量甲泼尼龙冲击治疗,静脉滴注甲泼尼龙0.5 g/d,连续3 d,之后改为口服泼尼松1~2 mg·kg-1·d-1。4例患者分别在用药5~18 d后出现不同程度精神障碍,表现为兴奋、言语增多、焦虑、躁狂、不能入睡,甚至出现被害妄想、自杀倾向等。逐渐减少激素用量并加用镇静及抗精神病药物治疗19 d至